Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/87542
DC FieldValueLanguage
dc.contributor.advisorSeiça, Raquel-
dc.contributor.advisorMatafome, Paulo-
dc.contributor.authorRodrigues, Tiago Daniel Almeida-
dc.date.accessioned2019-09-12T14:03:54Z-
dc.date.available2019-09-12T14:03:54Z-
dc.date.issued2019-09-11-
dc.date.submitted2019-03-30-
dc.identifier.urihttps://hdl.handle.net/10316/87542-
dc.descriptionTese no âmbito do Programa de Doutoramento em Ciências da Saúde, ramo de Ciências Biomédicas, apresentada à Faculdade de Medicina da universidade de Coimbra.pt
dc.description.abstractBackground and aims: Adipose tissue has a crucial role in metabolism and is nowadays recognized as an endocrine organ that produces and potentially secrets more than 600 factors involved in several physiological processes. Adipose tissue dysfunction is associated with increased insulin resistance and systemic dysmetabolism, which contributes to the development of metabolically unhealthy obesity and type 2 diabetes. Methylglyoxal-induced glycation is commonly associated with microvascular dysfunction, namely during chronic hyperglycemia, being a hypothetic factor underlying the impairment of adipose tissue microvasculature and ultimately, tissue dysfunction. Glucagon-like peptide-1 (GLP-1) based therapeutic approaches, specifically metabolic surgery and GLP-1 analogue treatment, have pleiotropic effects, including improved adipose tissue homeostasis, insulin signalling and glucose tolerance. Thus, we hypothesised that methylglyoxal-induced glycation has adverse effects on periepididymal adipose tissue vasculature, expandability and function, which could be targeted by GLP-1-based strategies through glyoxalase-1-dependent mechanisms. Accordingly, our main goal was to evaluate the role of glycation-induced microvascular dysfunction in adipose tissue function, exploring the mechanisms involved and the role of GLP-1-based therapies. Methods: Wistar rats supplemented with methylglyoxal and/or maintained with high-fat diet, were studied regarding periepididymal adipose tissue vasculature and function, namely addressing tissue hypoxia and local and systemic insulin resistance. For the first time, dynamic contrast-enhanced magnetic resonance imaging and adipose tissue angiogenesis assay have been used to quantify rat periepididymal adipose tissue blood flow and angiogenesis, respectively. Additionally, the role of glyoxalase-1 activity in human visceral adipose tissue and systemic metabolism was assessed in a cohort of obese patients (diabetic and non-diabetic). The role of GLP-1-based therapies on adipose tissue glycation was studied in type 2 diabetic Goto-Kakizaki rats (GK) maintained with high-calorie diet and submitted to sleeve gastrectomy (surgical model) and liraglutide-treated GK rats (pharmacological model). The glyoxalase-1-dependent mechanisms in adipose tissue and systemic metabolic profile were studied, as well as the role of liraglutide in preventing methylglyoxal-induced impairment of angiogenesis and modulating glyoxalase-dependent angiogenesis in adipose tissue by matrigel plug and adipose tissue angiogenesis assays, respectively. Kruskal-Wallis test (all pairwise multiple comparisons) was applied, being p<0.05 considered as the criterion for significance. Results: For the first time, our group demonstrated that methylglyoxal supplementation to high-fat diet-induced obese rats impairs periepididymal adipose tissue capillarization and blood flow, causing increased periepididymal adipose tissue hypoxia and insulin resistance as well as systemic and muscle insulin resistance and glucose intolerance. In turn, the adipose tissue angiogenic assay showed decreased capillarization after dose-dependent methylglyoxal exposure and glyoxalase-1 inhibition. Insulin resistant patients have shown a progressive decline in pancreatic -cell and adipose tissue function, which were exacerbated in diabetic obese patients, including decreased serum HDL cholesterol and adiponectin and visceral adipose tissue glyoxalase-1 activity. In visceral adipose tissue from obese patients the activity of this enzyme was negatively correlated with HbA1c. Animal models of vertical sleeve gastrectomy and liraglutide treatment have shown restored periepididymal adipose tissue levels and activity of glyoxalase-1. Liraglutide-treated rats also showed increased levels of periepididymal adipose tissue angiogenic and vasoactive factors, and insulin signalling. Moreover, liraglutide prevented negative methylglyoxal-induced effects on matrigel plug assay, being also effective in increasing periepididymal adipose tissue angiogenesis in a glyoxalase-1-dependent manner. Conclusions: Methylglyoxal-induced glycation impairs periepididymal adipose tissue expandability and function, contributing to insulin resistance and to the onset of metabolically unhealthy obesity. Lower visceral adipose tissue glyoxalase-1 activity follows the progressive decline of adipose tissue function, and is negatively associated with metabolic dysregulation in obese patients. Furthermore, glyoxalase-1 is a target for GLP-1-based therapeutic approaches, improving periepididymal adipose tissue function and insulin sensitivity, preventing early metabolic dysregulation, metabolically unhealthy obesity and type 2 diabetes development.pt
dc.language.isoengpt
dc.rightsopenAccesspt
dc.subjectAdipose tissuept
dc.subjectGlycationpt
dc.subjectMicrovasculaturept
dc.subjectAngiogenesispt
dc.subjectMethylglyoxalpt
dc.subjectGLP-1pt
dc.subjectLiraglutidept
dc.subjectInsulin resistancept
dc.subjectObesitypt
dc.subjectType 2 diabetespt
dc.titleAGEing Fat – Exploring The Mechanisms Of Glycation-Induced Microvascular Dysfunction In Adipose Tissuept
dc.typedoctoralThesispt
degois.publication.locationCoimbrapt
dc.peerreviewedyespt
dc.date.embargo2019-09-11*
dc.identifier.tid101611838pt
dc.subject.fosDomínio/Área Científica::Ciências Médicaspt
thesis.degree.disciplineID03018071-
thesis.degree.grantor00500::Universidade de Coimbrapt
thesis.degree.leveldoutor-
thesis.degree.nameDoutoramento em Ciências da Saúdept
thesis.degree.grantorUnit00506::Universidade de Coimbra - Faculdade de Medicinapor
uc.date.periodoembargo0por
uc.rechabilitacaoestrangeiranopt
uc.date.periodoEmbargo0pt
item.openairetypedoctoralThesis-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.grantfulltextopen-
item.fulltextCom Texto completo-
crisitem.advisor.researchunitCNC - Center for Neuroscience and Cell Biology-
crisitem.advisor.orcid0000-0002-8378-0895-
crisitem.advisor.orcid0000-0002-3422-290X-
Appears in Collections:FMUC Medicina - Teses de Doutoramento
UC - Teses de Doutoramento
Show simple item record

Page view(s)

347
checked on Mar 26, 2024

Download(s)

337
checked on Mar 26, 2024

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.